We have taken the most successful point of care diagnostic and made it universal

Glucose monitors are the most successful point of care diagnostic, accounting for 90% of the market ($15bn), due to their reliability, speed, ease of use, and low cost of manufacturing

Using synthetic biology techniques, Prof. Alexandrov reengineered the enzyme present in glucose monitors, glucose dehydrogenase (GDH), to make it activable upon binding of any analyte of interest

Our patent protected system can thus perform a wide range of molecular diagnostics, while keeping the same advantages of glucose monitors